Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population

Metabolism: Clinical and Experimental

Volumn 45, Issue 6, 1996, Pages 699-706

  Schmidt, Maria Inês ^b   Watson, Robert L ^a   Duncan, Bruce B ^b   Metcalf, Patricia ^b   Brancati, Frederick L ^b   Sharrett, A Richey ^b   Davis, C E ^b   Heiss, Gerardo ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; URIC ACID;

ADULT; ARTICLE; BODY MASS; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; INSULIN RESPONSE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OBESITY; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

EID: 0029887286     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90134-1     Document Type: Article

References (64)

1. Ferrannini E, Haffner SM, Mitchell BD, et al: Hyperinsulinaemia: A key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422, 1991
2. Haffner SM, Valdez RA, Hazuda HP, et al: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41:714-722, 1992
3. Zimmet PZ, Collins VR, Dowse GK, et al: Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome? Mixed findings in Asian Indian, Creole and Chinese Mauritians. Diabetic Med 11:388-396, 1994
4. Vague J: The degree of masculine differentiation of obesities: A factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr 4:20-34, 1956
5. Larsson B, Svardsudd K, Welin L, et al: Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J 288:1401-1404, 1984
6. Lapidus L, Bengtsson C, Larsson B, et al: Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 289:1257-1261, 1984
7. Bjorntorp P: The associations between obesity, adipose tissue distribution and disease. Acta Med Scand [Suppl] 723:121-134, 1988
8. Folsom AR, Burke GL, Ballew C, et al: Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites. The role of insulin. Am J Epidemiol 130:911-924, 1989
9. Terry RB, Page WF, Haskell WL: Waist/hip ratio, body mass index and premature cardiovascular disease mortality in US Army veterans during a twenty-three year follow-up study. Int J Obes 16:417-423, 1992
10. Prineas RJ, Folsom AR, Kaye SA: Central adiposity and increased risk of coronary artery disease mortality in older women. Ann Epidemiol 3:35-41, 1993
11. Folsom AR, Kaye SA, Sellers TA, et al: Body fat distribution and 5-year risk of death in older women. JAMA 269:483-487, 1993
12. Kaplan N: The deadly quartet - Upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 149:1514-1520, 1989
13. Bjorntorp P: "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493-496, 1990
14. Kissebah AH: Insulin resistance in visceral obesity. Int J Obes 15:109-115, 1991
15. Peters N, Hales CN: Plasma insulin after myocardial infarction. Lancet 1:1144-1145, 1965
16. Nikkilä EA, Miettinen TA, Vesenne MR, et al: Plasma insulin in coronary heart disease. Response to oral and intravenous glucose and tolbutamide. Lancet 2:500-511, 1965
17. Welborn TA, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration. Diabetes Care 2:154-160, 1979
18. Pyörälä K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland. Diabetes Care 2:131-141, 1979
19. Ducimetiere P, Eschwege E, Papoz L, et al: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205-210, 1980
20. Olefsky JM, Farquahar JW, Reaven GM: Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 57:551-560, 1974
21. Orchard TJ, Becker DJ, Bates M: Plasma insulin and lipoprotein concentrations: An atherogenic association? Am J Epidemiol 118:326-337, 1983
22. Modan M, Halkin H, Almog S, et al: Hyperinsulinemia - A link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817, 1985
23. Hunt SC, Wu LL, Hopkins PN, et al: Apolipoprotein, low-density lipoprotein subfraction and insulin associations with familial combined hyperlipidemia: Study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis 9:335-344, 1989
24. Modan M, Halkin H, Karasik A, et al: Elevated serum uric acid - A facet of hyperinsulinemia. Diabetologia 30:713-718, 1987
25. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
26. DeFronzo RA, Ferranini E: Insulin resistance - A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and other atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
27. Deprés J-P, Marette A: Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipidol 5:274-289, 1994
28. Taskinen M-R: Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 6:153-160, 1995
29. Reaven GM: Role of insulin resistance in human disease (syndrome X): An expanded definition. Annu Rev Med 44:121-131, 1993
30. Lindahl B, Asplund K, Hallmans G: High serum insulin, insulin resistance and their associations with cardiovascular risk factors: The Northern Sweden MONICA Population Study. J Intern Med 234:263-270, 1993
31. Lind L, Lithell H, Pollare T: Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors? J Hypertens 11:S11-S16, 1993 (suppl 4)
32. Mykännen L, Rönnemaa T, Laakso M: Low insulin sensitivity is associated with a clustering of cardiovascular risk factors. Diabetes 43:150A, 1994 (suppl 1, abstr)
33. Nabulsi AA, Folsom AR, Heiss G, et al: Fasting hyperinsulinemia and cardiovascular disease risk factors in nondiabetic adults: Stronger associations in lean versus obese subjects. Metabolism 44:914-922, 1995
34. ARIC Investigators: The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. Am J Epidemiol 129:687-702, 1989
35. 2-producing reactions. I. The determination of uric acid concentrations. J Clin Chem Clin Biochem 14:101-107, 1976
36. Nagele U, Hagele EO, Sauer G, et al: Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Biochem 22:165-174, 1984
37. 2+ precipitation. Clin Chem 28:1574, 1982 (abstr)
38. The National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
39. The Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: The 1984 Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 144:1045-1057, 1984
40. NCEP Adult Treatment Panel II: Summary of the Second Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 269:3015-3023, 1993
41. Woodley M, Whelan A (eds): Manual of Medical Therapeutics. Department of Medicine, Washington University School of Medicine (ed 27). Boston, MA, Little, Brown, 1992, p. 518
42. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, NY, Wiley, 1989, pp 1-133
43. Kleinbaum DG, Kupper LL, Muller KE: Applied Regression Analysis and Other Multivariable Methods. Boston, MA, PWS-Kent, 1988, pp 206-219
44. Facchini F, Chen YDI, Hollenbeck CB, et al: Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:3008-3011, 1991
45. Bonora E, Zavaroin J, Alpi O, et al: Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects. Diabetologia 30:719-723, 1987
46. Ferrannini E: Insulin and blood pressure: Possible role of hemodynamics. Clin Exp Hypertens Theory Pract A14:271-284, 1992
47. Baron AD, Brechtel-Hook G, Johnson A, et al: Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension 21:129-135, 1993
48. Baron AD: Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone. Baillière's Clin Endocrinol Metab 7:961-987, 1993
49. Lind L, Lithell H: Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia and hyperinsulinemia. Am Heart J 125:1494-1497, 1993
50. Vuorinen-Markkola H, Yki-Jarvinen H: Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 78:25-29, 1994
51. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
52. Arnesen H (ed): The Metabolic Cardiovascular Syndrome. J Cardiovasc Pharmacol 20:S1-S53, 1992 (suppl 8)
53. Tikkanen MS, Tuomilehto J: Multiple metabolic syndrome (syndrome X). Ann Med 24:461-489, 1992
54. Slattery ML, McDonald A, Bild DE, et al: Associations of body fat and its distribution with dietary intake, physical activity, alcohol, and smoking in blacks and whites. Am J Clin Nutr 55:943-949, 1992
55. Duncan BB, Chambless LE, Schmidt MI, et al: Correlates of body fat distribution - Variation across categories of race, sex and body mass in the Atherosclerosis Risk in Communities Study. Ann Epidemiol 5:192-200, 1995
56. Lissner L, Bengtsson C, Lapidus L, et al: Smoking initiation and cessation in relation to body fat distribution based on data from a study of Swedish women. Am J Public Health 82:273-275, 1992
57. Duncan BB, Chambless LE, Schmidt MI, et al: Association of the waist-to-hip ratio is different with wine than with beer or hard liquor consumption. Am J Epidemiol 142:1034-1038, 1995
58. Feskens EJM, Loeber JG, Kromhout D: Diet and physical activity as determinants of hyperinsulinemia: The Zupten Elderly Study. Am J Epidemiol 140:350-360, 1994
59. Prichard BNC (ed): Insulin Sensitivity: Cardioprotection vs. Metabolic Disorders. J Cardiovasc Pharmacol 20:S1-S84, 1992 (suppl 11)
60. Scientific Seminar. Eur Heart J 13:1-108, 1992 (suppl G)
61. Johnston CI, Cooper ME, Nicholls GM: Meeting report of the International Society of Hypertension Conference on Hypertension and Diabetes. J Hypertens 10:393-397, 1992
62. Hall JE (ed): The Kidney, Obesity, and Essential Hypertension Symposium. Hypertension 19:11-1129, 1992 (suppl)
63. Samuelsson O, Hedner T, Berglund G, et al: Diabetes mellitus in treated hypertension: Incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years' treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden. J Hum Hypertens 8:257-263, 1994
64. Haffner SM, Mykkänen L, Valdez RA, et al: Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J Clin Endocrinol Metab 79:1806-1810, 1994